Media Resources

SHARE PAGE:
Share on facebook Share on twitter Share on email

Press Release for Diagnostics and Health Facility Media Tour

Medanta-AfriCare will formally be launched this Monday, 21st May, 2012, by the Prime Minister, Rt.Hon. Raila A. Odinga, EGH, MP. The health facility is an investment of RJ Corp an Indian Multinational group in collaboration with, Medanta-The MediCity, India and local partner Intex Construction Group, names with a track record in consumer satisfaction and care.

Addressing Media Houses who had toured the ultra modern health facility, Anup Das, CEO, Medanta-AfriCare noted that “Our goal is to provide world class, proficient, high Quality & affordable Healthcare centers which can cater to health needs of the people of East Africa and deliver healthcare in a committed & compassionate way.”

The State-of-the-art infrastructure at Medanta-AfriCare diagnostics center provides transformational medical technologies and services that are shaping the new age of patient care. “Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems and performance improvement is helping clinicians re-imagine new ways to predict, diagnose, inform and treat disease, so their patients can live their lives to the fullest,” says Anup Das.

The tour of the facility showcased the capacity for patients to get access to:

  • Diagnostic testing; information and services that patients and doctors need to make better healthcare decisions. Services range from routine blood tests — such as total cholesterol, Pap testing and white blood cell count — to complex, gene-based and molecular testing.
  • Siemens Magnetom Verio 3 Tesla MRI system a global standard imaging equipment which is best in class to detect small tumours thus helping in early diagnosis of tumours and their recurrence. Also considered the best for imaging blood flow in the body like heart diseases, tumour surgeries etc– helping doctors decide treatment plan more effcieintly. 3T Magnetom Verio MRI – the last word in MR Imaging.
  • The Siemens Definition AS+ 256 slice, dual source dual energy scanner a state-of-the-art Multidetector CT scanner that is capable of the highest quality of coronary artery imaging – help in preventive screening of heart diseases. Low radiation output compared to other CT scans – better for pregnant ladies and children.
  • The Siemens Acuson S2000 Ultrasound and Color Doppler system is the S-class of ultrasound machines, with unmatched resolution for ultrasound of body organs, pregnancies, musculo-skeletal diseases like arthritis etc. Facilities for ultrasound-guided biopsy, FNAC and drainage of collections are also available which can reduce surgical procedures and hospital stays
  • State-of-the-art digital mammography unit is a direct DR system (with no film screen artifacts or image degradation) and offers unmatched digital resolution of breast tissue with a low radiation dose – helps in screening and managing patients with risk of breast cancer.
  • State-of-the art digital X-ray system ensures high resolution X-rays of any body part with a low radiation dose.

Dr C.V.Nerikar who is heading the global operations for healthcare division for RJ Corp which includes cord blood banking (Cryobanks International India), birthing centers(Cocoon) said “we need to reach the population of Kenya ,provide on time services and evidence based diagosostics .” Dr Nerikar also reiterated that our focus is on providing best and world class healthcare service and create more opportunities in Kenya.

In conclusion Dr C.V.Nerikar said, “Over the next 3-5years, we will set up 100 plus multi-specialty health centers across East Africa to start with, aiming at providing precise diagnosis & medical treatment to the people at affordable costs. This is our foray in the provision of world class healthcare focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention and the provision transformational medical technologies and services that are shaping the new age of patient care.”

About Medanta Africare

Medanta Africare is a vision shared by renowned Indian and African brands RJ Corp, Intex Group, Medanta-The Medicity, names which have a track record of highest level of consumer satisfaction and who believe and practice “Quality First” as their core belief. Medanta Africare intends “To provide world class, proficient, Quality & affordable Healthcare centers which can cater to health needs of the people of Africa and deliver healthcare in a committed & compassionate way.” Medanta Africare healthcare services by follow the highly successful Indian healthcare delivery model which focuses on ensuring highest quality at affordable rates for masses.

The entire team is focused and trained in best of class patient oriented services and we strive to satisfy patient needs; reducing patients’ waiting time, provide education and create awareness among clients and patients alike to have regular health check-ups.

To enhance our relationship with the medical community we intend to bring best of class technology, training programs and create forums for active transfer of ideas and practices between the Indian and African medical community.

Fred Hutchison breakthrough uses umbilical cord blood

SEATTLE - A major breakthrough in cancer treatment has been by scientists here in Washington.

The Fred Hutchinson Cancer Center cleared a hurdle in the use of umbilical cord blood - using a new life to help save another.

The breakthrough could make umbilical-cord-blood transplants a more widely-used method for treating blood cancers like leukemia.

"I mean it's amazing," says Colleen Delaney of the Fred Hutchison Center.

"You can take someone else's trash - right when a baby is born you gives life to that infant - but at the same time you can save the cells from the umbilical cord and give life to someone else who potentially needs a life-saving transplant."

Delaney says researchers have expanded core blood cells before, but they've never seen a significant clinical benefit.

But this time the center got results in an effort to decrease the time patients go without white blood cells.

Delaney says: "I think what this study shows is that we've definitively shown that we can do this - that we can manipulate cells in the laboratory, infuse them in patients and actually see some benefit in terms of early recovery of white cells. We cut the time almost in half of recovery of white blood cells."

Researchers say on average it took 14 days for the transplanted cells to engraft. In the past, it took four weeks using non-expanded units of cord blood.

This time, seven of the 10 patients survived with no evidence of disease.

Ages of the patients involved in the research ranged between 3 and 43. Researchers now plan on more clinical trials - and hope to spread their new findings.

"Very excited," Delaney says. "My patients are really my heroes and this is a tremendous step forward."

So - as one life begins, another could be saved.

Ages of the patients involved in the research ranged between 3 and 43. Researchers now plan on more clinical trials - and hope to spread their new findings.